CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > Australian Journal of Chemistry   
Australian Journal of Chemistry
Journal Banner
  An international journal for chemical science
blank image Search
blank image blank image
blank image
  Advanced Search

Journal Home
About the Journal
Editorial Structure
For Advertisers
Online Early
Current Issue
Just Accepted
All Issues
Virtual Issues
Special Issues
Research Fronts
Sample Issue
For Authors
General Information
Submit Article
Author Instructions
Open Access
For Referees
Referee Guidelines
Review an Article
For Subscribers
Subscription Prices
Customer Service
Print Publication Dates
Library Recommendation

blue arrow e-Alerts
blank image
Subscribe to our Email Alert or RSS feeds for the latest journal papers.

red arrow Connect with us
blank image
facebook twitter logo LinkedIn

Affiliated with RACI

Royal Australian Chemical Institute
Royal Australian
Chemical Institute


Article << Previous     |     Next >>   Contents Vol 65(12)

Structural and In Vitro Biological Studies of Organotin(iv) Precursors; Selective Inhibitory Activity Against Human Breast Cancer Cells, Positive to Estrogen Receptors

Vasilis I. Balas A, Christina N. Banti A B, Nikolaos Kourkoumelis C, Sotiris K. Hadjikakou A H, George D. Geromichalos D, Despina Sahpazidou D, Louise Male E, Mike B. Hursthouse E, Barbara Bednarz A F, Maciej Kubicki F, Konstantinos Charalabopoulos B G and Nick Hadjiliadis A H

A Section of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece.
B Department of Experimental Physiology, Medical School, University of Ioannina, 45110 Ioannina, Greece.
C Medical Physics Laboratory, Medical School, University of Ioannina, 45110 Ioannina, Greece.
D Cell Culture, Molecular Modeling and Drug Design Laboratory, Symeonidion Research Center, Theagenion Cancer Hospital, 54007 Thessaloniki, Greece.
E Department of Chemistry, University of Southampton, Highfield, Southampton, SO17 1BJ, UK.
F Department of Chemistry, Adam Mickiewicz University, ul. Grunwaldzka 6, 60-780 Poznan, Poland.
G Department of Physiology, Democritus University Medical School, 68100 Alexandroupolis, Greece.
H Corresponding authors. Email: shadjika@uoi.gr, nhadjis@uoi.gr

Australian Journal of Chemistry 65(12) 1625-1637 http://dx.doi.org/10.1071/CH12448
Submitted: 28 September 2012  Accepted: 24 October 2012   Published: 26 November 2012

PDF (1.5 MB) $25
 Supplementary Material
 Export Citation

Crystals of Ph3SnCl (1) were grown from a methanol/acetonitrile solution. Compounds [Ph3SnOH]n (2) and [(Ph2Sn)4Cl2O2(OH)2] (3) were crystallized from diethyl ether/methanol/acetonitrile and hot acetone/water solutions respectively, of the white precipitation, formed by adding KOH to solutions of 1 and [Ph2SnCl2] in 1 : 1 and 1 : 2 molar ratios respectively. Complex 1 was characterized by X-ray crystallography. X-ray structure determination of compounds 2 and 3 confirmed the previously reported identities. The molecular structure of 1, reported here, is a new polymorphic form of the known one for Ph3SnCl. Four independent [Ph3SnCl] molecules constitute the crystal structure of 1. The moieties are packed in two pairs in a tail-to-tail arrangement.

Complexes 13 were evaluated for their in vitro cytotoxic activity (cell viability) against human cancer cell lines: HeLa (human cervical), MCF-7 (breast, estrogen receptor (ER) positive), MDA-MB-231 (breast, ER negative), A549 (lung), Caki-1 (kidney carcinoma), 786-O (renal adenocarcinoma), K1 (thyroid carcinoma), and the normal human lung cell line MRC-5 (normal human fetal lung fibroblast cells) versus, the normal immortalized human mammary gland epithelial cell line MTSV17 with a sulforhodamine B (SRB) assay. The results show potent cytotoxic activity of the complexes against all cell lines used, which was superior to that of cisplatin (CDDP). Compounds 13 showed higher activity against breast cancer cells MCF-7 (ER positive) than against of MDA-MB-231 (ER negative). These findings prompted us to search for possible interaction of these complexes with other cellular elements of fundamental importance in cell proliferation. The influence of these complexes 13 upon the catalytic peroxidation of linoleic acid to hydroperoxylinoleic acid by the enzyme lipoxygenase (LOX), as well as their binding affinity towards calf thymus-DNA, were kinetically and theoretically studied.


[1]  (a) B. A. Buck-Koehntop, F. Porcelli, J. L. Lewin, C. J. Cramer, G. Veglia, J. Organomet. Chem. 2006, 691, 1748.
         | CrossRef | CAS |
      (b) K. E. Appel, Drug Metab. Rev. 2004, 36, 763.
         | CrossRef |

[2]     (a) “R.E.D. Facts: Triphenyltin Hydroxide”, EPA-738-F-99–014, November 1999 (US EPA).
         (b) A. G. Davies, Organotin Chemistry 2004 (Wiley-VCH: Weinheim).

[3]  M. Gajda, A. Jancso, “Organotins, formation, use, speciation and toxicology”, Metal Ions in Life Sciences 2010, Ch 7 (RSC Publishing: Cambridge).

[4]  (a) M. S. Rose, Biochem. J. 1969, 111, 129.
         | CAS |
      (b) B. M. Elliott, W. N. Aldridge, Biochem. J. 1977, 163, 583.
      (c) K. R. Siebenlist, F. Taketa, Biochem. J. 1986, 233, 471.
      (d) G. Zolese, R. Gabbianelli, G. C. Caulini, E. Bertoli, G. Falcioni, Proteins 1999, 34, 443.
         | CrossRef |

[5]  (a) W. N. Aldridge, B. W. Street, Biochem. J. 1970, 118, 171.
         | CAS |
      (b) K. Cain, D. E. Griffiths, Biochem. J. 1977, 162, 575.
      (c) A. P. Dawson, M. J. Selwyn, Biochem. J. 1974, 138, 349.
      (d) A. P. Dawson, B. G. Farrow, M. J. Selwyn, Biochem. J. 1982, 202, 163.
      (e) M. S. Rose, E. A. Lock, Biochem. J. 1970, 120, 151.

[6]  D. K. Apps, C. W. Lorna, Biochem. Biophys. Res. Commun. 1996, 227, 839.
         | CrossRef | CAS |

[7]  (a) J. J. Chicano, J. Ortiz, J. A. Teruel, F. J. Aranda, Biochim. Biophys. Acta 2001, 1510, 330.
         | CrossRef | CAS |
      (b) J. Sarapuk, H. Kleszczynska, S. Przestalski, Appl. Organomet. Chem. 2000, 14, 40.
         | CrossRef |

[8]  (a) Z. Yang, T. Bakas, A. Sanchez-Diaz, K. Charalabopoulos, J. Tsangaris, N. Hadjiliadis, J. Inorg. Biochem. 1998, 72, 133.
         | CrossRef | CAS |
      (b) L. Ghys, M. Biesemans, M. Gielen, A. Garoufis, N. Hadjiliadis, R. Willem, J. C. Martins, Eur. J. Inorg. Chem. 2000, 513.
         | CrossRef |
      (c) L. Nagy, B. Gyurcsik, K. Burger, S. Yamashita, T. Yamaguchi, H. Wakita, M. Nomura, Inorg. Chim. Acta 1995, 230, 105.
         | CrossRef |
      (d) L. Nagy, T. Yamaguchi, K. Yoshida, Struct. Chem. 2003, 14, 77.
         | CrossRef |
      (e) L. Nagy, A. Szorcsik, J. Inorg. Biochem 2002, 89, 1.
         | CrossRef |
      (f) L. Nagy, T. Yamaguchi, K. Yoshida, Struct. Chem. 2003, 14, 77.
         | CrossRef |
      (g) H. Baratne-Jankovics, I. Nagy, L. Pellerito, N. Buzas, R. Barbieri, J. Inorg. Chem. 2002, 92, 55.
      (h) A. Jancso, L. Nagy, E. Moldrheim, E. Sletten, J. Chem. Soc., Dalton Trans. 1999, 1587.
         | CrossRef |

[9]  (a) K. Fent, Crit. Rev. Toxicol. 1996, 26, 3.
         | CrossRef |
      (b) K. R. Siebenlist, F. Taketa, Biochem. J. 1986, 233, 471.
      (c) H. Stridh, I. Cotgreave, M. Muller, S. Orrenius, D. Gigliotti, Chem. Res. Toxicol. 2001, 14, 791.
         | CrossRef |

[10]  (a) S. K. Hadjikakou, N. Hadjiliadis, Coord. Chem. Rev. 2009, 253, 235.
         | CrossRef | CAS |
         (b) Tin compounds and their therapeutic potential, Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine (Eds M. Gielen, E. R. T. Tiekink) 2005 (John Wiley & Sons: Chichester).
      (c) A. K. Saxena, F. Huber, Coord. Chem. Rev. 1989, 95, 109.
         | CrossRef |

[11]  (a) S. Tabassum, C. Pettinari, J. Organomet. Chem. 2006, 691, 1761.
         | CrossRef | CAS |
      (b) C. Pellerito, P. D’Agati, T. Fiore, C. Mansueto, V. Mansueto, G. Stocco, L. Nagy, L. Pellerito, J. Inorg. Biochem. 2005, 99, 1294.
         | CrossRef |
      (c) F. Cima, L. Ballarin, Appl. Organomet. Chem. 1999, 13, 697.
         | CrossRef |

[12]  (a) M. N. Xanthopoulou, S. K. Hadjikakou, N. Hadjiliadis, M. Kubicki, S. Karkabounas, K. Charalabopoulos, N. Kourkoumelis, T. Bakas, J. Organomet. Chem. 2006, 691, 1780.
         | CrossRef | CAS |
      (b) M. N. Xanthopoulou, S. K. Hadjikakou, N. Hadjiliadis, M. Schurmann, K. Jurkschat, A. Michaelides, S. Skoulika, T. Bakas, J. Binolis, S. Karkabounas, K. Charalabopoulos, J. Inorg. Biochem. 2003, 96, 425.
         | CrossRef |
      (c) M. N. Xanthopoulou, S. K. Hadjikakou, N. Hadjiliadis, E. R. Milaeva, J. A. Gracheva, V.-Y. Tyurin, N. Kourkoumelis, K. C. Christoforidis, A. K. Metsios, S. Karkabounas, K. Charalabopoulos, Eur. J. Med. Chem. 2008, 43, 327.
         | CrossRef |
      (d) M. N. Xanthopoulou, S. K. Hadjikakou, N. Hadjiliadis, M. Kubicki, S. Skoulika, T. Bakas, M. Baril, I. S. Butler, Inorg. Chem. 2007, 46, 1187.
         | CrossRef |

[13]  (a) V. I. Balas, I. I. Verginadis, G. D. Geromichalos, N. Kourkoumelis, L. Male, M. B. Hursthouse, K. H. Repana, E. Yiannaki, K. Charalabopoulos, T. Bakas, S. K. Hadjikakou, Eur. J. Med. Chem. 2011, 46, 2835.
         | CrossRef | CAS |
      (b) V. I. Balas, S. K. Hadjikakou, N. Hadjiliadis, N. Kourkoumelis, M. E. Light, M. Hursthouse, A. K. Metsios, S. Karkabounas, Bioinorganic Chem. Applic. 2008,
         | CrossRef |
      (c) D. B. Shpakovsky, C. N. Banti, G. Beaulieu-Houle, N. Kourkoumelis, M. Manoli, M. J. Manos, A. J. Tasiopoulos, S. K. Hadjikakou, E. R. Milaeva, K. Charalabopoulos, T. Bakas, I. S. Butler, N. Hadjiliadis, Dalton Trans. 2012,
         | CrossRef |

[14]  (a) L. Rocamora-Reverte, E. Carrasco-Garc, J. Ceballos-Torres, S. Prashar, G. N. Kaluderovic, J. A. Ferragut, S. Gomez-Ruiz, ChemMedChem 2012, 7, 301.
         | CrossRef | CAS |
      (b) A. Ortiz, J. A. Teruel, F.J. Aranda, Biochimica et Biophysica Acta 2005, 1720, 137.
         | CrossRef |
      (c) G. Pavlakovic, M. D. Kane, C. L. Eyer, A. Kanthasamy, G. E. Isom, J. Neurochem. 1995, 65, 2338.
         | CrossRef |

[15]  A. Kafer, H. F. Krug, Environ. Health Perspect. 1994, 3, 325.

[16]  (a) B. Samuelsson, S. E. Dahlen, J. Lindgren, C. A. Rouzer, C. N. Serhan, Science 1987, 237, 1171.
         | CrossRef | CAS |
      (b) M. J. Knapp, J. P. Klinman, Biochemistry 2003, 42, 11466.
         | CrossRef |
      (c) X.-Z. Ding, C. A. Kuszynski, T. H. El-Metwally, T. E. Adrian, Biochem. Biophys. Res. Commun. 1999, 266, 392.
         | CrossRef |

[17]  (a) N. G. Bokii, G. N. Zakharova, Yu. T. Struchkov, J. Struct. Chem. 1970, 11, 247.
         | CrossRef |
      (b) J. S. Tse, F. L. Lee, E. J. Gabe, Acta Crystallogr. Sect. C: Cryst. Struct. Commun. 1986, 42, 1876.
      (c) S. Weng Ng, Acta Crystallogr Sect. C: Cryst. Struct. Commun. 1995, 51, 2292.
         | CrossRef |

[18]  (a) C. Glidewell, D. C. Liles, Acta Crystallogr. B 1978, 34, 129.
         | CrossRef |
      (b) C. Glidewell, J. N. Low, J. A. S. Bomfim, C. A. L. Filgueiras, J. L. Wardell, Acta Crystallogr. Sect. C: Cryst. Struct. Commun. 2002, 58, m199.
         | CrossRef |
      (c) C.-x. Fu, J.-h. Zhang, C.-l. Ma, Z.-t. Zhang, Chin. J. Synth. Chem. 2003, 11, 189.

[19]  (a) J. F. Vollano, R. O. Day, R. R. Holmes, Organometallics 1984, 3, 745.
         | CrossRef | CAS |
      (b) E. R. T. Tiekink, Acta Crystallogr., Sect. C. Cryst. Struct. Commun. 1991, 47, 661.
         | CrossRef |
      (c) R. A. Kresinski, R. J. Staples, J. P. Fackler, Acta Crystallogr. Sect. C: Cryst. Struct. Commun. 1994, 50, 40.
      (d) M. J. Cox, E. R. Tiekink, Z. Kristallogr. 1994, 209, 622.
         | CrossRef |

[20]  (a) V. Boudnitskaya, I. G. Borisova, FEBS Lett. 1972, 24, 359.
         | CrossRef |
      (b) F. Husson, Y. Pagot, S. Kermasha, J. M. Belin, Enzyme Microb. Technol. 1998, 23, 42.
         | CrossRef |

[21]  I. I. Ozturk, A. K. Metsios, S. Filimonova-Orlova, N. Kourkoumelis, S. K. Hadjikakou, M. Manos, A. J. Tasiopoulos, S. Karkabounas, E. R. Milaeva, N. Hadjiliadis, Med. Chem. Res. 2012, 21, 3523.
         | CrossRef | CAS |

[22]  (a) C. N. Banti, A. D. Giannoulis, N. Kourkoumelis, A. M. Owczarzak, M. Poyraz, M. Kubicki, K. Charalabopoulos, S. K. Hadjikakou, Metallomics 2012, 4, 545.
         | CrossRef | CAS |
      (b) C. N. N’soukpoe-Kossi, C. Descoteaux, E. Asselin, H. A. Tajmir-Riahi, G. Berube, DNA Cell Biol. 2008, 27, 101.
         | CrossRef |

[23]  H. Niyazi, J. P. Hall, K. O’Sullivan, G. Winter, T. Sorensen, J. M. Kelly, C. J. Cardin, Nat. Chem. 2012, 4, 621.
         | CrossRef | CAS |

[24]  M. H. Hanigan, P. Devarajan, Cancer Ther. 2003, 1, 47.

[25]     (a) G. M. Sheldrick, University of Göttingen, Germany 1997.
      (b) M. C. Burla, R. Caliandro, B. Carrozzini, G. Cascarano, L. De Caro, C. Giacovazzo, G. Polidori, J. Appl. Cryst. 2004, 37, 258.
         | CrossRef |

[26]     (a) A. Gorman, J. McCarthy, D. Finucane, W. Reville, T. Cotter, Techniques in Apoptosis. A User’s Guide (Eds T. G. Cotter, S. J. Martin) 1996, pp. 6 (Portland Press Ltd: London, UK).
      (b) P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, M. R. Boyd, J. Natl. Cancer Inst. 1990, 82, 1107.
         | CrossRef |
      (c) K. T. Papazisis, G. D. Geromichalos, K. A. Dimitriadis, A. H. Kortsaris, J. Immunol. Methods 1997, 208, 151.
         | CrossRef |

[27]  (a) R. Thomsen, M. H. Christensen, J. Med. Chem. 2006, 49, 3315.
         | CrossRef | CAS |
      (b) R. Abagyan, M. Totrov, J. Mol. Biol. 1994, 235, 983.
         | CrossRef |
      (c) R. Abagyan, M. Totrov, D. Kuznetsov, J. Comput. Chem. 1994, 15, 488.
         | CrossRef |
      (d) G. Nemethy, K. D. Gibson, K. A. Palmer, C. N. Yoon, G. Paterlini, A. Zagari, S. Rumsey, H. A. Scheraga, J. Phys. Chem. 1992, 96, 6472.
         | CrossRef |

Subscriber Login


Legal & Privacy | Contact Us | Help


© CSIRO 1996-2016